Middle East & Africa - Saudi Arabia, South Africa, and Turkey Internal Neurostimulation/Neuromodulation Market [Spinal Cord Stimulation, Vagus Nerve Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electric Neurostimulation] - Forecasts till 2019
The internal neuromodulation market in Saudi Arabia, South Africa, and Turkey is a fast emerging market. The growth of this market is driven by factors such as public initiatives to increase awareness, technological developments, growing demand for the use of advanced technologies, and the increasingly aging population. However, factors such as the disadvantages of a dearth of skilled professional and the reimbursement scenario restrain the growth of this market.
The report has been broadly classified into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electric neurostimulation. The spinal cord stimulator segment is further categorized on the basis of application into chronic pain, failed back surgery syndrome, ischemic pain, and others. Likewise, the deep brain stimulation market has its application in Parkinson’s disease, tremors, depression, and others that include chronic pain, dystonia, Tourette’s syndrome, and Alzheimer’s disease.
The sacral nerve stimulation market has applications in urinary incontinence and fecal incontinence. Vagus nerve stimulator comprises epilepsy and other applications; gastric stimulation includes gastroparaeisis and others. The gastric neurostimulator market segment is estimated to grow at the highest CAGR from 2014 to 2019. The drivers for this market are the increase in the number of people who suffer from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which is a major opportunity for players in this segment.
The market is estimated to be dominated by Medtronic Inc. (U.S.), St. Jude Medical Inc. (U.S.), Boston Scientific Inc. (U.S.) Aleva Neurotherapeutics SA (U.S.) Cyberonics Inc. (U.S.), Enteromedics Inc. (U.S.), and Uroplasty, Inc. (U.S.) New product launches & partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the internal neuromodulation market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various applications of particular modalities of the internal neuromodulation market. The in-depth industry analysis of drivers, inhibitors, and industry trends has been captured in the report. The report also presents the therapy/modality market share analysis of top players country-wise and the company profiles of major companies of the market. It comprises and discusses the rudimentary views on the competitive landscape, emerging- and high-growth segments of the internal neuromodulation market, high-growth regions & countries & their respective regulatory policies.
The report will enrich both the established firms as well as new entrants/smaller firms. It gauges the pulse of the market, which in turn will help the firms garner the larger market share and better market presence. Firms that purchase the report could use any one or a combination of five strategies that include market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market share/presence.
The report provides insights on the following pointers:
The report has been broadly classified into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, and gastric electric neurostimulation. The spinal cord stimulator segment is further categorized on the basis of application into chronic pain, failed back surgery syndrome, ischemic pain, and others. Likewise, the deep brain stimulation market has its application in Parkinson’s disease, tremors, depression, and others that include chronic pain, dystonia, Tourette’s syndrome, and Alzheimer’s disease.
The sacral nerve stimulation market has applications in urinary incontinence and fecal incontinence. Vagus nerve stimulator comprises epilepsy and other applications; gastric stimulation includes gastroparaeisis and others. The gastric neurostimulator market segment is estimated to grow at the highest CAGR from 2014 to 2019. The drivers for this market are the increase in the number of people who suffer from severe GERD and gastroparesis. Most incidences of delayed bowel movement go unnoticed, which is a major opportunity for players in this segment.
The market is estimated to be dominated by Medtronic Inc. (U.S.), St. Jude Medical Inc. (U.S.), Boston Scientific Inc. (U.S.) Aleva Neurotherapeutics SA (U.S.) Cyberonics Inc. (U.S.), Enteromedics Inc. (U.S.), and Uroplasty, Inc. (U.S.) New product launches & partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the internal neuromodulation market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various applications of particular modalities of the internal neuromodulation market. The in-depth industry analysis of drivers, inhibitors, and industry trends has been captured in the report. The report also presents the therapy/modality market share analysis of top players country-wise and the company profiles of major companies of the market. It comprises and discusses the rudimentary views on the competitive landscape, emerging- and high-growth segments of the internal neuromodulation market, high-growth regions & countries & their respective regulatory policies.
The report will enrich both the established firms as well as new entrants/smaller firms. It gauges the pulse of the market, which in turn will help the firms garner the larger market share and better market presence. Firms that purchase the report could use any one or a combination of five strategies that include market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market share/presence.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on internal neurostimulation/neuromodulation modalities offered by the top 10 players in the market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the internal neuromodulation market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF INTERNAL NEUROSTIMULATION/ NEUROMODULATION MARKET
2.2 ARRIVING AT THE neuromostimulation/neuromodulation MARKET SIZE
2.2.1 MARKET SHARE
2.2.2 TOP-DOWN APPROACH
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS and INHIBITORS
5 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY MODALITY
5.1 INTRODUCTION
5.2 SPINAL CORD STIMULATION
5.3 DEEP BRAIN STIMULATION
5.4 SACRAL NERVE STIMULATION
5.5 VAGUS NERVE STIMULATON
5.6 GASTRIC ELECTRICAL STIMULATION (GES)
6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET,BY APPLICATION
6.1 INTRODUCTION
6.1.1 SPINAL CORD STIMULATION (SCS) MARKET, BY APPLICATION/ GEOGRAPHY
6.1.1.1 Spinal Cord Stimulation (SCS) Market, by Application
6.1.1.2 Spinal Cord Stimulation (SCS) Market, by Geography
6.1.2 DEEP BRAIN STIMULATION (DBS) MARKET, BY APPLICATION/ GEOGRAPHY
6.1.2.1 Deep Brain Stimulation (DBS) Market, by Application
6.1.2.2 Deep Brain Stimulation (DBS) Market, by Geography
6.1.3 SACRAL NERVE STIMULATION (SNS) MARKET, BY APPLICATION/ GEOGRAPHY
6.1.3.1 Sacral Nerve Stimulation (SNS) Market, by Application
6.1.3.2 Sacral Nerve Stimulation (SNS) Market, by Geography
6.1.4 VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION/GEOGRAPHY
6.1.4.1 Vagus Nerve Stimulation (VNS) Market, by Application
6.1.4.2 Vagus Nerve Stimulation (VNS) Market, by Geography
6.1.5 GASTRIC ELECTRICAL STIMULATION (GES) MARKET, BY APPLICATION/ GEOGRAPHY
6.1.5.1 Gastric Electrical Stimulation (GES) Market, by Application
6.1.5.2 Gastric Electrical Stimulation (GES) Market, by Geography
7 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPETITIVE LANDSCAPE
7.1 Company share analysis: by Modality
7.1.1 SPINAL CORD STIMULATION
7.1.2 DEEP BRAIN STIMULATION
7.1.3 SACRAL NERVE STIMULATION
7.1.4 VAGUS NERVE STIMULATION
7.2 COMPANY PRESENCE IN internal neurostimulation/ neuromodulationMARKET
8 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY COMPANY
8.1 BOSTON SCIENTIFIC CORPORATION (U.S.)
8.2 CERBOMED GMBH (GERMANY)
8.3 CYBERONICS, INC. (U.S.)
8.4 ENTEROMEDICS, INC. (U.S.)
8.5 MEDTRONIC, INC. (U.S.)
8.6 ST. JUDE MEDICAL (U.S.)
8.7 SYNAPSE BIOMEDICAL, INC. (U.S.)
8.8 UROPLASTY, INC. (U.S.)
9 APPENDIX
9.1 CUSTOMIZATION OPTIONS
9.1.1 PRODUCT ANALYSIS
9.1.2 EPIDEMIOLOGY DATA
9.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS
9.1.4 REGULATORY FRAMEWORK
9.2 RELATED REPORTS
9.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
9.3.1 SNAPSHOTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF INTERNAL NEUROSTIMULATION/ NEUROMODULATION MARKET
2.2 ARRIVING AT THE neuromostimulation/neuromodulation MARKET SIZE
2.2.1 MARKET SHARE
2.2.2 TOP-DOWN APPROACH
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS and INHIBITORS
5 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY MODALITY
5.1 INTRODUCTION
5.2 SPINAL CORD STIMULATION
5.3 DEEP BRAIN STIMULATION
5.4 SACRAL NERVE STIMULATION
5.5 VAGUS NERVE STIMULATON
5.6 GASTRIC ELECTRICAL STIMULATION (GES)
6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET,BY APPLICATION
6.1 INTRODUCTION
6.1.1 SPINAL CORD STIMULATION (SCS) MARKET, BY APPLICATION/ GEOGRAPHY
6.1.1.1 Spinal Cord Stimulation (SCS) Market, by Application
6.1.1.2 Spinal Cord Stimulation (SCS) Market, by Geography
6.1.2 DEEP BRAIN STIMULATION (DBS) MARKET, BY APPLICATION/ GEOGRAPHY
6.1.2.1 Deep Brain Stimulation (DBS) Market, by Application
6.1.2.2 Deep Brain Stimulation (DBS) Market, by Geography
6.1.3 SACRAL NERVE STIMULATION (SNS) MARKET, BY APPLICATION/ GEOGRAPHY
6.1.3.1 Sacral Nerve Stimulation (SNS) Market, by Application
6.1.3.2 Sacral Nerve Stimulation (SNS) Market, by Geography
6.1.4 VAGUS NERVE STIMULATION (VNS) MARKET, BY APPLICATION/GEOGRAPHY
6.1.4.1 Vagus Nerve Stimulation (VNS) Market, by Application
6.1.4.2 Vagus Nerve Stimulation (VNS) Market, by Geography
6.1.5 GASTRIC ELECTRICAL STIMULATION (GES) MARKET, BY APPLICATION/ GEOGRAPHY
6.1.5.1 Gastric Electrical Stimulation (GES) Market, by Application
6.1.5.2 Gastric Electrical Stimulation (GES) Market, by Geography
7 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPETITIVE LANDSCAPE
7.1 Company share analysis: by Modality
7.1.1 SPINAL CORD STIMULATION
7.1.2 DEEP BRAIN STIMULATION
7.1.3 SACRAL NERVE STIMULATION
7.1.4 VAGUS NERVE STIMULATION
7.2 COMPANY PRESENCE IN internal neurostimulation/ neuromodulationMARKET
8 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET, BY COMPANY
8.1 BOSTON SCIENTIFIC CORPORATION (U.S.)
8.2 CERBOMED GMBH (GERMANY)
8.3 CYBERONICS, INC. (U.S.)
8.4 ENTEROMEDICS, INC. (U.S.)
8.5 MEDTRONIC, INC. (U.S.)
8.6 ST. JUDE MEDICAL (U.S.)
8.7 SYNAPSE BIOMEDICAL, INC. (U.S.)
8.8 UROPLASTY, INC. (U.S.)
9 APPENDIX
9.1 CUSTOMIZATION OPTIONS
9.1.1 PRODUCT ANALYSIS
9.1.2 EPIDEMIOLOGY DATA
9.1.3 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS
9.1.4 REGULATORY FRAMEWORK
9.2 RELATED REPORTS
9.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
9.3.1 SNAPSHOTS
LIST OF TABLES
TABLE 1 GLOBAL INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET, 2012 – 2019 (USD MILLION)
TABLE 2 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 3 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET IN SAUDI ARABIA, SOUTH AFRICA, AND TURKEY: DRIVERS AND INHIBITORS
TABLE 4 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN SOUTH AFRICA, BY MODALITY, 2013 - 2019 (USD THOUSAND)
TABLE 5 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN TURKEY, BY MODALITY, 2012 – 2019 (USD THOUSAND)
TABLE 6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN SAUDI ARABIA, BY MODALITY, 2012 – 2019 (USD THOUSAND)
TABLE 7 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY,2013–2019 (USD THOUSAND)
TABLE 8 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY,2012–2019 (USD THOUSAND)
TABLE 9 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY,2013–2019 (USD THOUSAND)
TABLE 10 VAGUS NERVE STIMULATIONMARKET, BY GEOGRAPHY,2012–2019 (USD MN)
TABLE 11 GASTRIC ELECTRICAL STIMULATION MASKS MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
TABLE 12 SPINAL CORD STIMULATION (SCS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 13 SPINAL CORD STIMULATION (SCS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 14 SPINAL CORD STIMULATION (SCS) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 15 CHRONIC PAIN SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 16 FAILED BACK SURGERY SYNDROME SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 17 ISCHEMIA SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 18 DEEP BRAIN STIMULATION (DBS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 19 DEEP BRAIN STIMULATION (DBS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 20 DEEP BRAIN STIMULATION (DBS) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 21 PARKINSON’S DISEASE SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 22 TREMOR SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 23 DEPRESSION SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,BY GEOGRAPHY, 2013 - 2019 (USD THOUSAND)
TABLE 24 SACRAL NERVE STIMULATION (SNS) MARKET IN SOUTH AFRICA,BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 25 SACRAL NERVE STIMULATION (SNS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 26 SACRAL NERVE STIMULATION (SNS) MARKET IN SAUDI ARABIA,BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 27 URINARY INCONTINENCE SEGMENT IN SACRAL NERVE STIMULATION (SNS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 28 FECAL INCONTINENCE SEGMENT IN SACRAL NERVE STIMULATION (SNS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 29 VAGUS NERVE STIMULATION (VNS) MARKET IN SOUTH AFRICA,BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 30 VAGUS NERVE STIMULATION (VNS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 31 VAGUS NERVE STIMULATION (VNS) MARKET IN SAUDI ARABIA,BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 32 EPILEPSY SEGMENT IN VAGUS NERVE STIMULATION (VNS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 33 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012- 2019 (USD THOUSAND)
TABLE 34 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN TURKEY,BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 35 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 36 GASTROPARESIS SEGMENT IN GASTRIC ELECTRICAL STIMULATION (GES) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 37 BOSTON SCIENTIFIC CORPORATION: KEY FINANCIALS, BY SEGMENTS, 2009 – 2013 (USD MILLION)
TABLE 38 BOSTON SCIENTIFIC: KEY FINANCIALS, BY GEOGRAPHY, 2009 – 2012 (USD MILLION)
TABLE 39 CYBERONICS, INC.: KEY FINANCIALS, 2009 - 2013 (USD MILLION)
TABLE 40 MEDTRONIC, INC.: KEY FINANCIALS, BY SEGMENTS, 2009 - 2013 (USD MILLION)
TABLE 41 MEDTRONIC, INC.: KEY FINANCIALS, 2009 - 2013 (USD MILLION)
TABLE 42 ST. JUDE MEDICAL: KEY FINANCIALS, BY SEGMENTS, 2011 - 2013 (USD MILLION)
TABLE 43 ST. JUDE MEDICAL: KEY FINANCIALS, BY GEOGRAPHY,2008 - 2013 (USD MILLION)
TABLE 44 UROPLASTY, INC.: KEY FINANCIALS, BY GEOGRAPHY,2011 - 2013 (USD MILLION)
TABLE 1 GLOBAL INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET, 2012 – 2019 (USD MILLION)
TABLE 2 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 3 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET IN SAUDI ARABIA, SOUTH AFRICA, AND TURKEY: DRIVERS AND INHIBITORS
TABLE 4 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN SOUTH AFRICA, BY MODALITY, 2013 - 2019 (USD THOUSAND)
TABLE 5 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN TURKEY, BY MODALITY, 2012 – 2019 (USD THOUSAND)
TABLE 6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN SAUDI ARABIA, BY MODALITY, 2012 – 2019 (USD THOUSAND)
TABLE 7 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY,2013–2019 (USD THOUSAND)
TABLE 8 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY,2012–2019 (USD THOUSAND)
TABLE 9 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY,2013–2019 (USD THOUSAND)
TABLE 10 VAGUS NERVE STIMULATIONMARKET, BY GEOGRAPHY,2012–2019 (USD MN)
TABLE 11 GASTRIC ELECTRICAL STIMULATION MASKS MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
TABLE 12 SPINAL CORD STIMULATION (SCS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 13 SPINAL CORD STIMULATION (SCS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 14 SPINAL CORD STIMULATION (SCS) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 15 CHRONIC PAIN SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 16 FAILED BACK SURGERY SYNDROME SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 17 ISCHEMIA SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 18 DEEP BRAIN STIMULATION (DBS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 19 DEEP BRAIN STIMULATION (DBS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 20 DEEP BRAIN STIMULATION (DBS) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 21 PARKINSON’S DISEASE SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 22 TREMOR SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 23 DEPRESSION SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,BY GEOGRAPHY, 2013 - 2019 (USD THOUSAND)
TABLE 24 SACRAL NERVE STIMULATION (SNS) MARKET IN SOUTH AFRICA,BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 25 SACRAL NERVE STIMULATION (SNS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 26 SACRAL NERVE STIMULATION (SNS) MARKET IN SAUDI ARABIA,BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 27 URINARY INCONTINENCE SEGMENT IN SACRAL NERVE STIMULATION (SNS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 28 FECAL INCONTINENCE SEGMENT IN SACRAL NERVE STIMULATION (SNS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 29 VAGUS NERVE STIMULATION (VNS) MARKET IN SOUTH AFRICA,BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 30 VAGUS NERVE STIMULATION (VNS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 31 VAGUS NERVE STIMULATION (VNS) MARKET IN SAUDI ARABIA,BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 32 EPILEPSY SEGMENT IN VAGUS NERVE STIMULATION (VNS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 33 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012- 2019 (USD THOUSAND)
TABLE 34 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN TURKEY,BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 35 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
TABLE 36 GASTROPARESIS SEGMENT IN GASTRIC ELECTRICAL STIMULATION (GES) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
TABLE 37 BOSTON SCIENTIFIC CORPORATION: KEY FINANCIALS, BY SEGMENTS, 2009 – 2013 (USD MILLION)
TABLE 38 BOSTON SCIENTIFIC: KEY FINANCIALS, BY GEOGRAPHY, 2009 – 2012 (USD MILLION)
TABLE 39 CYBERONICS, INC.: KEY FINANCIALS, 2009 - 2013 (USD MILLION)
TABLE 40 MEDTRONIC, INC.: KEY FINANCIALS, BY SEGMENTS, 2009 - 2013 (USD MILLION)
TABLE 41 MEDTRONIC, INC.: KEY FINANCIALS, 2009 - 2013 (USD MILLION)
TABLE 42 ST. JUDE MEDICAL: KEY FINANCIALS, BY SEGMENTS, 2011 - 2013 (USD MILLION)
TABLE 43 ST. JUDE MEDICAL: KEY FINANCIALS, BY GEOGRAPHY,2008 - 2013 (USD MILLION)
TABLE 44 UROPLASTY, INC.: KEY FINANCIALS, BY GEOGRAPHY,2011 - 2013 (USD MILLION)
LIST OF FIGURES
FIGURE 1 NEUROSTIMULATION/NEUROMODULATION MARKET IN SAUDI ARABIA, SOUTH AFRICA, AND TURKEY: SEGMENTATION & COVERAGE
FIGURE 2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: INTEGRATED ECOSYSTEM
FIGURE 3 TOP-DOWN APPROACH
FIGURE 4 GLOBAL INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET, 2012 – 2018 (USD MILLION)
FIGURE 5 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN SOUTH AFRICA, BY MODALITY, 2013–2019 (USD THOUSAND)
FIGURE 7 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN TURKEY, BY MODALITY, 2013–2019 (USD THOUSAND)
FIGURE 8 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN TURKEY, BY MODALITY, 2013–2019 (USD THOUSAND)
FIGURE 9 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY,2013–2019 (USD THOUSAND)
FIGURE 10 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY,2013–2019 (USD THOUSAND)
FIGURE 11 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY,2013–2019 (USD THOUSAND)
FIGURE 12 VAGUS NERVE STIMULATIONMARKET, BY GEOGRAPHY, 2013–2019 (USD MN)
FIGURE 13 GASTRIC ELECTRICAL STIMULATION MASKS MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
FIGURE 14 SPINAL CORD STIMULATION (SCS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 15 SPINAL CORD STIMULATION (SCS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 16 SPINAL CORD STIMULATION (SCS) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 17 CHRONIC PAIN SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 18 FAILED BACK SURGERY SYNDROME SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 19 ISCHEMIA SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 20 DEEP BRAIN STIMULATION (DBS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 21 DEEP BRAIN STIMULATION (DBS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 22 DEEP BRAIN STIMULATION (DBS) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 23 PARKINSON’S DISEASE SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 24 TREMOR SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 25 DEPRESSION SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 26 SACRAL NERVE STIMULATION (SNS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 27 SACRAL NERVE STIMULATION (SNS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 28 SACRAL NERVE STIMULATION (SNS) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 29 URINARY INCONTINENCE SEGMENT IN SACRAL NERVE STIMULATION (SNS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 30 FECAL INCONTINENCE SEGMENT IN SACRAL NERVE STIMULATION (SNS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 31 VAGUS NERVE STIMULATION (VNS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 32 VAGUS NERVE STIMULATION (VNS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 33 VAGUS NERVE STIMULATION (VNS) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 34 EPILEPSY SEGMENT IN VAGUS NERVE STIMULATION (VNS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 35 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 36 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 37 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN SAUDI ARABIA,BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 38 GASTROPARESIS SEGMENT IN GASTRIC ELECTRICAL STIMULATION (GES) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 39 SOUTH AFRICA: SPINAL CORD STIMULATION, BY COMPANY, 2014
FIGURE 40 SAUDI ARABIA: SPINAL CORD STIMULATION, BY COMPANY, 2014
FIGURE 41 TURKEY: SPINAL CORD STIMULATION, BY COMPANY, 2014
FIGURE 42 SOUTH AFRICA: DEEP BRAIN STIMULATION, BY COMPANY, 2014
FIGURE 43 SAUDI ARABIA: DEEP BRAIN STIMULATION, BY COMPANY, 2014
FIGURE 44 TURKEY: DEEP BRAIN STIMULATION, BY COMPANY, 2014
FIGURE 45 SOUTH AFRICA: VAGUS NERVE STIMULATION, BY COMPANY, 2014
FIGURE 46 SAUDI ARABIA: VAGUS NERVE STIMULATION, BY COMPANY, 2014
FIGURE 47 TURKEY: VAGUS NERVE STIMULATION, BY COMPANY, 2014
FIGURE 48 INTERNAL NEUROSTIMULATION/ NEUROMODULATIONMARKET: COMPANY COVERAGE, BY PRODUCT, 2013
FIGURE 1 NEUROSTIMULATION/NEUROMODULATION MARKET IN SAUDI ARABIA, SOUTH AFRICA, AND TURKEY: SEGMENTATION & COVERAGE
FIGURE 2 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: INTEGRATED ECOSYSTEM
FIGURE 3 TOP-DOWN APPROACH
FIGURE 4 GLOBAL INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET: COMPARISON WITH PARENT MARKET, 2012 – 2018 (USD MILLION)
FIGURE 5 INTERNAL NEUROMODULATION/NEUROSTIMULATION MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 6 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN SOUTH AFRICA, BY MODALITY, 2013–2019 (USD THOUSAND)
FIGURE 7 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN TURKEY, BY MODALITY, 2013–2019 (USD THOUSAND)
FIGURE 8 INTERNAL NEUROSTIMULATION/NEUROMODULATION MARKET IN TURKEY, BY MODALITY, 2013–2019 (USD THOUSAND)
FIGURE 9 SPINAL CORD STIMULATION MARKET, BY GEOGRAPHY,2013–2019 (USD THOUSAND)
FIGURE 10 DEEP BRAIN STIMULATION MARKET, BY GEOGRAPHY,2013–2019 (USD THOUSAND)
FIGURE 11 SACRAL NERVE STIMULATION MARKET, BY GEOGRAPHY,2013–2019 (USD THOUSAND)
FIGURE 12 VAGUS NERVE STIMULATIONMARKET, BY GEOGRAPHY, 2013–2019 (USD MN)
FIGURE 13 GASTRIC ELECTRICAL STIMULATION MASKS MARKET, BY GEOGRAPHY, 2013–2019 (USD THOUSAND)
FIGURE 14 SPINAL CORD STIMULATION (SCS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 15 SPINAL CORD STIMULATION (SCS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 16 SPINAL CORD STIMULATION (SCS) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 17 CHRONIC PAIN SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 18 FAILED BACK SURGERY SYNDROME SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 19 ISCHEMIA SEGMENT IN SPINAL CORD STIMULATION (SCS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 20 DEEP BRAIN STIMULATION (DBS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 21 DEEP BRAIN STIMULATION (DBS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 22 DEEP BRAIN STIMULATION (DBS) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 23 PARKINSON’S DISEASE SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 24 TREMOR SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 25 DEPRESSION SEGMENT IN DEEP BRAIN STIMULATION (DBS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 26 SACRAL NERVE STIMULATION (SNS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 27 SACRAL NERVE STIMULATION (SNS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 28 SACRAL NERVE STIMULATION (SNS) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 29 URINARY INCONTINENCE SEGMENT IN SACRAL NERVE STIMULATION (SNS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 30 FECAL INCONTINENCE SEGMENT IN SACRAL NERVE STIMULATION (SNS) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 31 VAGUS NERVE STIMULATION (VNS) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 32 VAGUS NERVE STIMULATION (VNS) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 33 VAGUS NERVE STIMULATION (VNS) MARKET IN SAUDI ARABIA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 34 EPILEPSY SEGMENT IN VAGUS NERVE STIMULATION (VNS) MARKET,BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 35 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN SOUTH AFRICA, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 36 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN TURKEY, BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 37 GASTRIC ELECTRICAL STIMULATION (GES) MARKET IN SAUDI ARABIA,BY APPLICATION, 2012 – 2019 (USD THOUSAND)
FIGURE 38 GASTROPARESIS SEGMENT IN GASTRIC ELECTRICAL STIMULATION (GES) MARKET, BY GEOGRAPHY, 2012 – 2019 (USD THOUSAND)
FIGURE 39 SOUTH AFRICA: SPINAL CORD STIMULATION, BY COMPANY, 2014
FIGURE 40 SAUDI ARABIA: SPINAL CORD STIMULATION, BY COMPANY, 2014
FIGURE 41 TURKEY: SPINAL CORD STIMULATION, BY COMPANY, 2014
FIGURE 42 SOUTH AFRICA: DEEP BRAIN STIMULATION, BY COMPANY, 2014
FIGURE 43 SAUDI ARABIA: DEEP BRAIN STIMULATION, BY COMPANY, 2014
FIGURE 44 TURKEY: DEEP BRAIN STIMULATION, BY COMPANY, 2014
FIGURE 45 SOUTH AFRICA: VAGUS NERVE STIMULATION, BY COMPANY, 2014
FIGURE 46 SAUDI ARABIA: VAGUS NERVE STIMULATION, BY COMPANY, 2014
FIGURE 47 TURKEY: VAGUS NERVE STIMULATION, BY COMPANY, 2014
FIGURE 48 INTERNAL NEUROSTIMULATION/ NEUROMODULATIONMARKET: COMPANY COVERAGE, BY PRODUCT, 2013
